immupharma.org immupharma.org

immupharma.org

WELCOME to ImmuPharma | ImmuPharma

Skip to main content. Library of drug-like molecules. ImmuPharma currently has five lead compounds in development, each representing a potentially significant breakthrough in its field. Lupuzor , for the treatment of Lupus, recently received US FDA approval to enter Phase III with a Special Protocol Assessment and Fast Track designation. ImmuPharma is publicly listed in London, trading under the symbol IMM, or IMM:LN on Bloomberg. Term Sheet signed with US Investor to secure up to US$14 Mil.

http://www.immupharma.org/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IMMUPHARMA.ORG

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

April

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Wednesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.2 out of 5 with 10 reviews
5 star
6
4 star
2
3 star
1
2 star
0
1 star
1

Hey there! Start your review of immupharma.org

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

CONTACTS AT IMMUPHARMA.ORG

ImmuPharma plc

Dimitri Dimitriou

50 B●●●●dway

Lo●●on , SW1H 0BL

GB

44.7●●●●3222
di●●●●●●●●●●●●●●●@immupharma.com

View this contact

ImmuPharma plc

Dimitri Dimitriou

50 B●●●●dway

Lo●●on , SW1H 0BL

GB

44.7●●●●3222
di●●●●●●●●●●●●●●●@immupharma.com

View this contact

ImmuPharma plc

Dimitri Dimitriou

50 B●●●●dway

Lo●●on , SW1H 0BL

GB

44.7●●●●3222
di●●●●●●●●●●●●●●●@immupharma.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
n/a
UPDATED
2014 January 26
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

NAME SERVERS

1
ns45.1and1.co.uk
2
ns46.1and1.co.uk

REGISTRAR

1 & 1 Internet AG (R73-LROR)

1 & 1 Internet AG (R73-LROR)

WHOIS : whois.publicinterestregistry.net

REFERRED :

CONTENT

SCORE

6.2

PAGE TITLE
WELCOME to ImmuPharma | ImmuPharma | immupharma.org Reviews
<META>
DESCRIPTION
Skip to main content. Library of drug-like molecules. ImmuPharma currently has five lead compounds in development, each representing a potentially significant breakthrough in its field. Lupuzor , for the treatment of Lupus, recently received US FDA approval to enter Phase III with a Special Protocol Assessment and Fast Track designation. ImmuPharma is publicly listed in London, trading under the symbol IMM, or IMM:LN on Bloomberg. Term Sheet signed with US Investor to secure up to US$14 Mil.
<META>
KEYWORDS
1 news
2 aim rule 26
3 disclaimer
4 feedback
5 sitemap
6 about us
7 corporate strategy
8 research and development
9 business development
10 operations
CONTENT
Page content here
KEYWORDS ON
PAGE
news,aim rule 26,disclaimer,feedback,sitemap,about us,corporate strategy,research and development,business development,operations,management team,scientific collaborators,scientific advisory board,awards and grants,events and conferences,interviews,cancer
SERVER
Apache
POWERED BY
PHP/5.6.34
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

WELCOME to ImmuPharma | ImmuPharma | immupharma.org Reviews

https://immupharma.org

Skip to main content. Library of drug-like molecules. ImmuPharma currently has five lead compounds in development, each representing a potentially significant breakthrough in its field. Lupuzor , for the treatment of Lupus, recently received US FDA approval to enter Phase III with a Special Protocol Assessment and Fast Track designation. ImmuPharma is publicly listed in London, trading under the symbol IMM, or IMM:LN on Bloomberg. Term Sheet signed with US Investor to secure up to US$14 Mil.

INTERNAL PAGES

immupharma.org immupharma.org
1

Pain Relief Treatments | ImmuPharma

http://immupharma.org/pain-relief-treatments

Skip to main content. Scientific Publications (Lupuzor ). Library of drug-like molecules. Severe pain relief (IPP-102199). This once-a-day potential treatment for severe pain caused by serious conditions such as cancer and surgical procedures is based on the body’s internal analgesic, offering fewer side effects and potentially longer duration. ImmuPharma’s pain relief compound. How IPP-102199 works in pain relief.

2

Scientific Advisory Board | ImmuPharma

http://immupharma.org/scientific-advisory-board

Skip to main content. Scientific Publications (Lupuzor ). Library of drug-like molecules. Scientific Publications (Lupuzor ). Detailed biographies of the five Scientific Advisors are shown below. Dr Daniel J. Wallace, M.D., F.A.C.P., F.A.C.R (USA). Associate Director, Rheumatology Fellowship Program, Cedars-Sinai Medical Center, Los Angeles, Clinical Professor of Medicine, David Geffen School of Medicine at UCLA and Expert Reviewer, Medical Board of California. Prof Vibeke Strand, MD, FACP, FACR (USA).

3

Awards & Grants | ImmuPharma

http://immupharma.org/awards-grants

Skip to main content. Scientific Publications (Lupuzor ). Library of drug-like molecules. Scientific Publications (Lupuzor ). ImmuPharma has received the following awards:. Founder Dr Sylviane Muller. Dr Sylviane Muller recently awarded Medal of Innovation from CNRS for work on both Lupuzors. Mechanism of action and its applicability to other autoimmune conditions (some having orphan drug status). Click here for full announcement. CNRS/Dr Slyviane Muller video link. In 2014 the French region of Aquitaine...

4

Disclaimer | ImmuPharma

http://immupharma.org/disclaimer

Skip to main content. Scientific Publications (Lupuzor ). Library of drug-like molecules. This website contains certain statements that are not historical facts and may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those projected or suggested in any forward-looking statement made by ImmuPharma plc (“the company”). Special rules apply when US persons (as defined in t...

5

AIM Rule 26 | ImmuPharma

http://immupharma.org/aim-rule-26

Skip to main content. Scientific Publications (Lupuzor ). Library of drug-like molecules. AIM Rule 26 Information. The following information is being disclosed for the purposes of Rule 26 of the AIM Rules for Companies. Please click below for a description of the business. Corporate Governance and Committees. Country of Incorporation and Main Country of Operation. Country of Incorporation: England and Wales. Company Registration Number: 3929567. Main Country of Operation: France. Annual Report March 2006.

UPGRADE TO PREMIUM TO VIEW 15 MORE

TOTAL PAGES IN THIS WEBSITE

20

OTHER SITES

immupet.com immupet.com

金沙国际娱乐网址_金沙2055am官网_www3016.com澳门金沙

介護職員基礎研修は、介護福祉士養成のための実務者研修 介護福祉士実務者研修 へと、ホームヘルパー2級 訪問介護員養成研修課程 は 介護職員初任者研修 へと改編されています。 加えて、オレンジプラン 認知症施策推進5か年計画 など認知症に関わる施策が実施されている背景もあり、 認知症の理解 6時間 に関する科目が追加されています。

immupetplus.com immupetplus.com

ImmuPet+ Immune System Support

How can it help my pet? Daily immune support for your pet. They may think they are invincible, but our pets are no superheroes. They often need immune system support to keep them feeling super. That’s where ImmuPet comes in. ImmuPet works to support your pet’s immune response, meaning their immune system is functioning correctly, ready and willing to make the most of the nutrients you provide it. We use these trusted payment providers:. Join our mailing list. Great news, we've signed you up.

immupharma.biz immupharma.biz

Lupuzor

Rigerimod): for the treatment of lupus. Aiming to bring a. Lupus is a chronic debilitating incurable inflammatory disease, sometimes fatal, associated with disorders of the immune system. A look at the science behind Lupuzor™ and its discovery by Europe's largest Research Institution. A glance at some of the clinical trial results with Lupuzor™ showing improvement in the condition of Lupus patients. The company behind it. A potential treatment for Lupus. Addressing an unmet need.

immupharma.info immupharma.info

Lupuzor

Rigerimod): for the treatment of lupus. Aiming to bring a. Lupus is a chronic debilitating incurable inflammatory disease, sometimes fatal, associated with disorders of the immune system. A look at the science behind Lupuzor™ and its discovery by Europe's largest Research Institution. A glance at some of the clinical trial results with Lupuzor™ showing improvement in the condition of Lupus patients. The company behind it. A potential treatment for Lupus. Addressing an unmet need.

immupharma.net immupharma.net

Lupuzor

Rigerimod): for the treatment of lupus. Aiming to bring a. Lupus is a chronic debilitating incurable inflammatory disease, sometimes fatal, associated with disorders of the immune system. A look at the science behind Lupuzor™ and its discovery by Europe's largest Research Institution. A glance at some of the clinical trial results with Lupuzor™ showing improvement in the condition of Lupus patients. The company behind it. A potential treatment for Lupus. Addressing an unmet need.

immupharma.org immupharma.org

WELCOME to ImmuPharma | ImmuPharma

Skip to main content. Library of drug-like molecules. ImmuPharma currently has five lead compounds in development, each representing a potentially significant breakthrough in its field. Lupuzor , for the treatment of Lupus, recently received US FDA approval to enter Phase III with a Special Protocol Assessment and Fast Track designation. ImmuPharma is publicly listed in London, trading under the symbol IMM, or IMM:LN on Bloomberg. Term Sheet signed with US Investor to secure up to US$14 Mil.

immupharma.us immupharma.us

Lupuzor

Rigerimod): for the treatment of lupus. Aiming to bring a. Lupus is a chronic debilitating incurable inflammatory disease, sometimes fatal, associated with disorders of the immune system. A look at the science behind Lupuzor™ and its discovery by Europe's largest Research Institution. A glance at some of the clinical trial results with Lupuzor™ showing improvement in the condition of Lupus patients. The company behind it. A potential treatment for Lupus. Addressing an unmet need.

immuplas.com immuplas.com

Imusyn

Imusyn GmbH and Co.KG • Feodor-Lynen-Str. 21 • 30625 Hannover. Tel 49 511 54481 42 • Fax 49 511 54481 43 •.

immupop.com immupop.com

InMotion Hosting

Your IP is 67.219.144.114.

immupro.com immupro.com

IMMUPRO - Immune System Enhancer Antioxidant formula

Is a comprehensive antioxidant formulation containing several natural phytoprotective nutrients which have been extensively shown in research centers and universities worldwide to have the potential of positively impacting the body's immune system by mobilizing it against various forms of cancer, coronary disease and infections. Is manufactured under strict quality control guidelines. All ingredients are tested for purity and potency prior to manufacturing through our Meta. Values yields the best results.

immupsora-oil.blogspot.com immupsora-oil.blogspot.com

Immupsora oil

Wednesday, December 17, 2008. Or psoriasis with large area. 1) It provides predictable antiproliferative, anti inflammatory and antibacterial action. 2) Systemic administration helps in correcting the immune dysfunction and abnormal cytokine release. 1) Bath only with mild soaps and when bathing keep the temperature of water-cool or warm not hot. 2) Moisturize your skin coconut oil or other moisturizer, they prevent skin crack. 3) Drink plenty of water and fruit juice. Flares up when you are under stress.